Funding backs a human-first approach to drug safety and efficacy, reducing reliance on animal testing and accelerating ...

Drug developers are seeking to speed up the testing and developing of new drugs with the help of artificial intelligence (AI). Researchers at universities and pharmaceutical giants are testing how AI ...

Glucagon-like peptide agonists (GLP-1s, like Ozempic, Wegovy, and Mounjaro) have been hailed as breakthroughs. From statins to Viagra, occasionally a drug development breakthrough occurs that is ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

One of the pillars of modern medicine is the life-saving drugs that pharmaceutical companies spend years developing to cure and prevent diseases. But what if they could do it faster and at a fraction ...

Smart multi-target drugs are redefining how we treat complex diseases by combining AI-driven discovery with mechanistic ...

In the final part of his Pharma Commerce video interview, Ed Schoonveld, value and access advisor for Schoonveld Advisory and ...

Written by Keynote Contributor Soroosh Afyouni, head of health data science at bioXcelerate AI. Every household seems to have that drawer of miscellaneous belongings. When you need something, you know ...

The rising global cancer burden continues to drive market expansion, with WHO reporting 20 million new cases and 9.7 million ...